FLUDARABINE PHOSPHATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

TEVA

Revision date : 2012-12-04

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

232-519-5/87-78-5

Name of the chemical

mannitol

Concentration

N/A

General Information

Revision date

2012-12-04

Product name

FLUDARABINE PHOSPHATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Chemical name

9H-Purin-6-amine, 2-fluoro-9-(5-0-phosphonoβ-D-arabino-furanosyl) (2-fluoro-ara-AMP)

1.2.2. Uses advised against

Other than Relevant Use

Manufacturer Name

TEVA

Emergency telephone

1-800/424-9300, 01-703-527-3887

Icons in SDS

M004 M009 M010 M011 M017 M059

Company Information

company name

TEVA

e-mail address of the competent person responsible for the Safety Data Sheet

TevaSDSRequest@tevapharm.com

Section 2

SECTION 2: Hazards identification

Product definition

This product is a white to off-white powder. Health Hazards WARNING! THIS PRODUCT CONTAINS A CYTOTOXIC AGENT. EXPOSURE BY ALL ROUTES MUST BE AVOIDED. In the workplace may be harmful by skin contact. Toxic by injection. May be harmful or fatal by inhalation and ingestion. There are scientific studies that suggest that personnel (e.g. nurses, pharmacists, etc.) who prepare and administer parenteral antineoplastics (e.g. in hospitals) may be at some risk due to potential mutagenicity, teratogenicity, or other reproductive effects of these materials if workplace exposures are not properly controlled. The actual risk in the workplace is not known. Therapeutic use can cause compromise of the immune system, cause depression of bone marrow, pulmonary toxicity, neurological toxicity, adverse central nervous system effects, rash, fever and eye infections, gastrointestinal, hematological, and hepatic effects and occasionally, cardiovascular effects. Fludarabine is a suspect mutagen and reproductive toxin for both genders, based on animal testing. May cause harm or be fatal to developing fetus. These effects may be possible as a result of workplace exposure. Refer to Section 11 (Toxicological Information) for additional information on adverse effects. Flammability Hazards: This compound requires substantial pre-heating before ignition occurs. As a finely-divided organic compound, the accumulation of dusts of this compound can create a serious hazard of explosion. When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds (including carbon and nitrogen oxides, and hydrogen fluoride). Reactivity Hazards: This product is not reactive. Environmental Hazards: This product has not been tested for environmental harm; all release to the environment should be avoided. Emergency Recommendations: Emergency responders must wear personal protective equipment suitable for the situation to which they are responding.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.